Data Driven Behavior Intervention and Medical Outcome Evaluation of Patients' Comprehensive Monitoring
试验速览
- 阶段
- 不适用
- 入组人数
- 1,000
- 主要终点
- Rate of metabolic complications
研究概览
简要总结
During the study, the resuscitation room, general wards and ICU were installed fixed or mobile acquisition devices in the resuscitation room, the emergency department of Peking Union Medical College Hospital, and the collection platform was set up. Patients with acute diseases (infection, diabetes complications, etc.) caused by metabolic syndrome (obesity, diabetes, etc.) were selected after informed consent. All medical intervention behaviors, relevant medical records and medical outcome records within the collection scope of the device platform were collected prospectively . And regular follow-up, guidance of patients with metabolic syndrome control, while collecting all the lifestyle characteristics of patients, some patients with metabolic cabin research, and observe the relevant medical outcomes. After that, all the collected data were coded, and the influence of all lifestyle and medical behavior interventions on patients' medical outcomes was studied by artificial intelligence method.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diabetes and / or obesity (BMI>=28).
- •Emergency room / emergency ward / EICU;
- •Be able to understand and agree the research protocol and sign the informed consent
排除标准
- •Pregnant women / lactation period;
- •The estimated survival time was less than 1 year;
- •Long term follow-up is not guaranteed;
- •Failure to comply with the protocol or procedure;
- •The collection of medical behavior data can not complete the de privacy or label after de privacy;
- •Other researchers think that it is not suitable for inclusion
结局指标
主要结局
Rate of metabolic complications
时间窗: 6 weeks
Relapse of acute metabolic disease, stability of biochemical metabolic indexes (such as glycosylated hemoglobin, BMI)
Rate of mortality
时间窗: 6 months
30-day and 90-day mortality. Death due to cardiovascualr complications
Complication control
时间窗: 3 weeks
The occurrence of metabolic complications, infection and cardiovascular events
次要结局
- Total cost of treatment(3 weeks)
- Quality of life(6 months)
